微RNA-409-3p/BTG2信号轴在肥胖小鼠中改善受损的血管生成和伤口愈合
Furkan Bestepe1, George F Ghanem1, Colette M Fritsche1
1Department of Medicine, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA.
概括
微RNA-409-3p通过抑制BTG2.2,加剧糖尿病伤口愈合中的血管生成障碍. 在2型糖尿病模型中,抑制这种microRNA促进了伤口的关闭和血管的形成.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物医学科学 生物医学科学
背景情况:
- 伤口愈合依赖于新血管生成,这对于组织修复至关重要.
- 2型糖尿病 (T2D) 损害了伤口愈合,部分原因是血管生成受损.
- 微RNAs调节血管生成,在T2D相关的愈合缺陷中具有潜在的作用.
研究的目的:
- 研究miR-409-3p在糖尿病伤口愈合和血管生成中的作用.
- 在内皮细胞中识别miR-409-3p的分子标和机制.
主要方法:
- 在T2D伤口和模型中分析miR-409-3p表达.
- 使用人类静脉内皮细胞 (HUVEC) 进行体外研究,以评估miR-409-3p对细胞生长,迁移和血管生成的影响.
- 用mRNA测序和光酶测试来识别和验证miR-409-3p的目标.
- 在体内研究使用内皮特异性的miR-409-3p淘汰赛小鼠与高血糖.
主要成果:
- 在T2D不愈合的伤口中,miR-409-3p表达升高.
- 中和 miR-409-3p 增强了 HUVEC 功能和体外血管生成;过度表达会损害它.
- BTG2被确定为miR-409-3p的直接标,其表达与反向相关.
- 内皮细胞中miR-409-3p缺乏导致mTOR酸化的增加.
- 在体内,miR-409-3p淘汰的小鼠表现出改善的伤口关闭,血管化和增加的BTG2表达.
结论:
- miR-409-3p是糖尿病患者皮肤伤口愈合中血管生成受损的关键调节剂.
- 向miR-409-3p代表了增强糖尿病伤口修复的潜在治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


